Long-term follow-up of patients who did not receive backup-marrow infusions (Philadelphia patients)
| Status and patient no. . | No. patients . | Follow-up, mo . |
|---|---|---|
| In hematologic remission, no. 1 | 1 | Prophylactic IFN, 79 + pABMT |
| On treatment with disease | 4 | |
| No. 7 | 71 + pABMT (hydroxyurea) | |
| No. 14 | 50 + pABMT (STI571) | |
| No. 15 | 51 + pABMT (STI571) | |
| No. 19 | 14 + pABMT | |
| Underwent allogeneic transplantation | 6 | |
| No. 2 | MUD 24 mo pABMT, died pMUD | |
| No. 3 | MUD 25 mo pABMT, died pMUD | |
| No. 6 | MUD 30 mo pABMT, died pMUD | |
| No. 5 | MUD 44 mo pABMT, alive, 24 mo pMUD | |
| No. 8 | MUD 45 mo pABMT, alive, 14 mo pMUD | |
| No. 17 | Allo 24 + mo pABMT, died pAllo5-150 | |
| Progressive disease, No. 18 | 1 | 12 + mo pABMT (deceased) |
| Status and patient no. . | No. patients . | Follow-up, mo . |
|---|---|---|
| In hematologic remission, no. 1 | 1 | Prophylactic IFN, 79 + pABMT |
| On treatment with disease | 4 | |
| No. 7 | 71 + pABMT (hydroxyurea) | |
| No. 14 | 50 + pABMT (STI571) | |
| No. 15 | 51 + pABMT (STI571) | |
| No. 19 | 14 + pABMT | |
| Underwent allogeneic transplantation | 6 | |
| No. 2 | MUD 24 mo pABMT, died pMUD | |
| No. 3 | MUD 25 mo pABMT, died pMUD | |
| No. 6 | MUD 30 mo pABMT, died pMUD | |
| No. 5 | MUD 44 mo pABMT, alive, 24 mo pMUD | |
| No. 8 | MUD 45 mo pABMT, alive, 14 mo pMUD | |
| No. 17 | Allo 24 + mo pABMT, died pAllo5-150 | |
| Progressive disease, No. 18 | 1 | 12 + mo pABMT (deceased) |
IFN indicates interferon; p, after; BMT, bone marrow transplantation; ABMT, auto bone marrow transplantation; MUD, transplantation from matched unrelated donor; Allo, allotransplantation.
This patient had an HLA-matched sibling who declined to donate BM for transplant but subsequently agreed to become a donor.